Hyundai Pharm Rises Over 8% After Previous Day's Limit-Up... Gains Widen in September
Hyundai Pharm is continuing its strong momentum, rising more than 8% in early trading on the 2nd, following a limit-up move the previous day. ■ Up 8.56% as of 9:04 a.m. on the 2nd As of 9:04 a.m. on the 2nd, Hyundai Pharm was trading at 9,000 won, up 710 won from the previous session, a gain of 8.

Hyundai Pharm is continuing its strong momentum, rising more than 8% in early trading on the 2nd, following a limit-up move the previous day.
■ Up 8.56% as of 9:04 a.m. on the 2nd
As of 9:04 a.m. on the 2nd, Hyundai Pharm was trading at 9,000 won, up 710 won from the previous session, a gain of 8.56%. During the session, it rose as high as 9,440 won, widening its gains, while the low was 7,720 won. Trading volume at the same time was tallied at approximately 3.07 million shares.
■ Rise follows previous day's limit-up... gains widen in September
Hyundai Pharm also rose to its price limit the previous day. On the 1st, it closed at 8,290 won, surging 1,910 won, or 29.94%, from the prior session, with volume of about 19.59 million shares.
Looking at the recent trend, the closing price, which was 6,010 won on the 27th of last month, climbed to 6,160 won on the 28th and 6,380 won on the 31st, before gains expanded sharply entering September.
■ A period of heightened volatility... supply-demand and disclosures warrant monitoring
On the order book, buy and sell orders are facing off around the 9,000-won level. With the stock's short-term gains having grown large, this is a zone where volatility could expand as intraday profit-taking volume collides with additional buying. In particular, with the strength continuing from the previous day's limit-up into today, short-term changes in supply and demand could have a greater influence on the stock's direction. Investors need to keep an eye on intraday volume, order book changes, and whether the company issues any disclosures.
[This article was written for informational purposes based on publicly available market information and data, and does not recommend buying, selling, or holding any specific stock. Stock investing involves the risk of principal loss, and the final investment decision and responsibility rest with the investor. This article was written with AI assistance.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Cyberattack via Optimizely Exposes 178 Global Organizations... CNN, BBC, HSBC, and Ledger Also Affected](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F11%2F627874%2Ffc472b72a2596aa1%2Fvariants%2Fhero.webp&w=1920&q=75)


